BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19541857)

  • 1. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.
    Lew JQ; Freedman ND; Leitzmann MF; Brinton LA; Hoover RN; Hollenbeck AR; Schatzkin A; Park Y
    Am J Epidemiol; 2009 Aug; 170(3):308-17. PubMed ID: 19541857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
    J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption and breast cancer risk in the Women's Health Study.
    Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
    Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
    Touillaud MS; Thiébaut AC; Fournier A; Niravong M; Boutron-Ruault MC; Clavel-Chapelon F
    J Natl Cancer Inst; 2007 Mar; 99(6):475-86. PubMed ID: 17374837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study.
    Park Y; Brinton LA; Subar AF; Hollenbeck A; Schatzkin A
    Am J Clin Nutr; 2009 Sep; 90(3):664-71. PubMed ID: 19625685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Wang SM; Pfeiffer RM; Gierach GL; Falk RT
    Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.
    Nyante SJ; Dallal CM; Gierach GL; Park Y; Hollenbeck AR; Brinton LA
    Am J Epidemiol; 2013 Aug; 178(3):359-71. PubMed ID: 23899816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
    Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
    Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
    Fournier A; Fabre A; Mesrine S; Boutron-Ruault MC; Berrino F; Clavel-Chapelon F
    J Clin Oncol; 2008 Mar; 26(8):1260-8. PubMed ID: 18323549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Daling JR
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1061-6. PubMed ID: 14578143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics.
    Falk RT; Maas P; Schairer C; Chatterjee N; Mabie JE; Cunningham C; Buys SS; Isaacs C; Ziegler RG
    Am J Epidemiol; 2014 Oct; 180(7):705-17. PubMed ID: 25150269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
    Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
    Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
    Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
    Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study.
    Horn-Ross PL; Canchola AJ; Bernstein L; Clarke CA; Lacey JV; Neuhausen SL; Reynolds P; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2006-13. PubMed ID: 22832206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
    Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
    Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women.
    Sellers TA; Vierkant RA; Cerhan JR; Gapstur SM; Vachon CM; Olson JE; Pankratz VS; Kushi LH; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1104-7. PubMed ID: 12376515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
    Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
    Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.